PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases

Documenti analoghi

• PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis
  di: Kostik, MM, et al.
  Pubblicazione: (2013)
• Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
  di: Kostik, Mikhail M, et al.
  Pubblicazione: (2014)
• How to identify a patient with autoinflammatory syndrome: Clinical and diagnostic algorithms
  di: Mikhail Mikhailovich Kostik, et al.
  Pubblicazione: (2013-10-01)
• Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease
  di: Egorov, Andrey, et al.
  Pubblicazione: (2014)
• Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
  di: Kostik, Mikhail M, et al.
  Pubblicazione: (2015)